These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 36838987)
1. Targeting Epigenetic Changes Mediated by Members of the SMYD Family of Lysine Methyltransferases. Padilla A; Manganaro JF; Huesgen L; Roess DA; Brown MA; Crans DC Molecules; 2023 Feb; 28(4):. PubMed ID: 36838987 [TBL] [Abstract][Full Text] [Related]
2. Structure of human lysine methyltransferase Smyd2 reveals insights into the substrate divergence in Smyd proteins. Xu S; Zhong C; Zhang T; Ding J J Mol Cell Biol; 2011 Oct; 3(5):293-300. PubMed ID: 21724641 [TBL] [Abstract][Full Text] [Related]
3. Functions of SMYD proteins in biological processes: What do we know? An updated review. Rueda-Robles A; Audano M; Álvarez-Mercado AI; Rubio-Tomás T Arch Biochem Biophys; 2021 Nov; 712():109040. PubMed ID: 34555372 [TBL] [Abstract][Full Text] [Related]
4. Structure and function of SET and MYND domain-containing proteins. Spellmon N; Holcomb J; Trescott L; Sirinupong N; Yang Z Int J Mol Sci; 2015 Jan; 16(1):1406-28. PubMed ID: 25580534 [TBL] [Abstract][Full Text] [Related]
5. Expression patterns and the prognostic value of the SMYD family members in human breast carcinoma using integrative bioinformatics analysis. Song J; Liu Y; Chen Q; Yang J; Jiang Z; Zhang H; Liu Z; Jin B Oncol Lett; 2019 Apr; 17(4):3851-3861. PubMed ID: 30930987 [TBL] [Abstract][Full Text] [Related]
6. The lysine methyltransferases SET and MYND domain containing 2 (Smyd2) and Enhancer of Zeste 2 (Ezh2) co-regulate osteoblast proliferation and mineralization. Dashti P; van de Peppel J; Thaler R; Paradise CR; Stein GS; Montecino MA; van Leeuwen JPTM; van der Eerden BJ; Dudakovic A; van Wijnen AJ Gene; 2023 Jan; 851():146928. PubMed ID: 36191822 [TBL] [Abstract][Full Text] [Related]
7. Proteomic analyses of the SMYD family interactomes identify HSP90 as a novel target for SMYD2. Abu-Farha M; Lanouette S; Elisma F; Tremblay V; Butson J; Figeys D; Couture JF J Mol Cell Biol; 2011 Oct; 3(5):301-8. PubMed ID: 22028380 [TBL] [Abstract][Full Text] [Related]
8. The SMYD family proteins in immunology: An update of their obvious and non-obvious relations with the immune system. Rubio-Tomás T Heliyon; 2021 Jun; 7(6):e07387. PubMed ID: 34235289 [TBL] [Abstract][Full Text] [Related]
10. Lysine methyltransferase Smyd2 regulates Hsp90-mediated protection of the sarcomeric titin springs and cardiac function. Voelkel T; Andresen C; Unger A; Just S; Rottbauer W; Linke WA Biochim Biophys Acta; 2013 Apr; 1833(4):812-22. PubMed ID: 23047121 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of the Value of SMYD Family Members in the Prognosis and Immune Infiltration of Malignant Digestive System Tumors. Liu D; Wang X; Shi E; Wang L; Nie M; Li L; Jiang Q; Kong P; Shi S; Wang C; Yan S; Qin Z; Zhao S Front Genet; 2021; 12():699910. PubMed ID: 34335697 [TBL] [Abstract][Full Text] [Related]
12. The Smyd Family of Methyltransferases: Role in Cardiac and Skeletal Muscle Physiology and Pathology. Tracy C; Warren JS; Szulik M; Wang L; Garcia J; Makaju A; Russell K; Miller M; Franklin S Curr Opin Physiol; 2018 Feb; 1():140-152. PubMed ID: 29435515 [TBL] [Abstract][Full Text] [Related]
13. Novel insights into SMYD2 and SMYD3 inhibitors: from potential anti-tumoural therapy to a variety of new applications. Rubio-Tomás T Mol Biol Rep; 2021 Nov; 48(11):7499-7508. PubMed ID: 34510321 [TBL] [Abstract][Full Text] [Related]
14. SMYD proteins: key regulators in skeletal and cardiac muscle development and function. Du SJ; Tan X; Zhang J Anat Rec (Hoboken); 2014 Sep; 297(9):1650-62. PubMed ID: 25125178 [TBL] [Abstract][Full Text] [Related]
15. Structure based functional annotation of a MYND-less lysine methyl transferase in Dey J; Kishore Prasad H Bioinformation; 2022; 18(12):1146-1153. PubMed ID: 37701516 [No Abstract] [Full Text] [Related]
16. SMYD Family Members Serve as Potential Prognostic Markers and Correlate with Immune Infiltrates in Gastric Cancer. Liu D; Liu M; Wang W; Li X; Shi E; Zhang C; Wang Y; Zhang Y; Wang L; Wang X J Oncol; 2023; 2023():6032864. PubMed ID: 36816359 [TBL] [Abstract][Full Text] [Related]
17. Histone-modifier gene expression profiles are associated with pathological and clinical outcomes in human breast cancer. Patani N; Jiang WG; Newbold RF; Mokbel K Anticancer Res; 2011 Dec; 31(12):4115-25. PubMed ID: 22199269 [TBL] [Abstract][Full Text] [Related]
18. Crystal structures of histone and p53 methyltransferase SmyD2 reveal a conformational flexibility of the autoinhibitory C-terminal domain. Jiang Y; Sirinupong N; Brunzelle J; Yang Z PLoS One; 2011; 6(6):e21640. PubMed ID: 21738746 [TBL] [Abstract][Full Text] [Related]
19. Function of the MYND Domain and C-Terminal Region in Regulating the Subcellular Localization and Catalytic Activity of the SMYD Family Lysine Methyltransferase Set5. Jaiswal D; Turniansky R; Moresco JJ; Ikram S; Ramaprasad G; Akinwole A; Wolf J; Yates JR; Green EM Mol Cell Biol; 2020 Jan; 40(2):. PubMed ID: 31685550 [TBL] [Abstract][Full Text] [Related]
20. Lysine Methyltransferase SMYD1 Regulates Myogenesis via skNAC Methylation. Zhu L; Brown MA; Sims RJ; Tiwari GR; Nie H; Mayfield RD; Tucker HO Cells; 2023 Jun; 12(13):. PubMed ID: 37443729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]